A suite of non-promotional resources to support primary care healthcare organisations to efficiently identify uncontrolled and suspected severe asthma patients for review, optimisation of treatment and where appropriate referral to specialist severe asthma services. Resources include clinical system searches, alerts, referral templates and reporting functionality which can be used at a practice, primary care network and system level to enable a population health approach.

When system level healthcare organisations such as integrated care boards (ICBs) register for SPECTRA they can also access the SPECTRA at Scale Action Learning Programme. The Action Learning programme aims to:

1. Improve the quality of care for patients with uncontrolled asthma
2. Equip healthcare professionals (HCPs) with the knowledge and skills to utilise all of the SPECTRA clinical system resources
3. Address quality improvement challenges

The SPECTRA at Scale Action Learning Programme engages HCPs in a problem-solving process that involves:

1. Reflection
2. Analysis
3. Action

SPECTRA has been developed to enable primary care healthcare organisations (HCO) to accelerate the identification of suspected severe asthma and improve the management of uncontrolled asthma in adult patients. SPECTRA resources are available for SystemOne and EMIS Web, the two largest primary care clinical systems in the UK. Both systems have inherent functionality which allows the import of pre-designed searches which may be used to interrogate a practice, primary care network or system level databases without visiting the practice.

For Vision practices, searches can be deployed remotely into GP systems through Vision+. Oberoi, as the third party provider, will work with Vision to notify them of the request to deploy the “pathway”.

Healthcare organisations can register for SPECTRA at http://www.suspected-severe-asthma.com and access SPECTRA searches, alerts and referral templates without sharing any patient level data with AstraZeneca.

Once practices have created the SPECTRA data file on their clinical system, they can choose to upload this to the SPECTRA portal, gaining access to reporting functionality at practice, network or system level. Before uploading SPECTRA data files, practices are notified that generating reports require sharing of aggregated numerical data with their Primary Care Network (PCN), Integrated Care Board (ICB) and AstraZeneca. Patient numbers between one and seven are suppressed on network and system level reports and dashboards, aligned to NHS Digital's approach to suppression of small patient counts.

SPECTRA reporting involves no processing of patients’ identifiable data and therefore no patient data is shared with any party, including AstraZeneca.

If you have any technical difficulties or wish to discuss IT governance please contact the AstraZeneca SPECTRA support team.

Telephone number: 01332 546909 
Email: support@suspected-severe-asthma.co.uk